Methods for managing miscarriage: a network meta‐analysis

J Ghosh, A Papadopoulou, AJ Devall… - Cochrane Database …, 2021 - cochranelibrary.com
Background Miscarriage, defined as the spontaneous loss of a pregnancy before 24 weeks'
gestation, is common with approximately 25% of women experiencing a miscarriage in their …

A sixty-year research and development of trichosanthin, a ribosome-inactivating protein

JQ Lu, KB Wong, PC Shaw - Toxins, 2022 - mdpi.com
Tian Hua Fen, a herbal powder extract that contains trichosanthin (TCS), was used as an
abortifacient in traditional Chinese medicine. In 1972, TCS was purified to alleviate the side …

[图书][B] Infertility in practice

A Balen - 2022 - taylorfrancis.com
This text has been written as a practical guide, based on the author's experience over the
last 40 years of daily clinical practice and aiming to place the modern approach to the …

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind …

C Hamel, S Coppus, J van den Berg, E Hink… - …, 2021 - thelancet.com
Background Worldwide, millions of women seek treatment for early pregnancy loss (EPL)
annually. Medical management with misoprostol is widely used, but only effective 60% of the …

Evaluation of clinical effects of Esketamine on depression in patients with missed miscarriage: a randomized, controlled, double-blind trial

M Jiang, Q Li, M Mao, C Xu, R Zhou, Y Wen… - Journal of Affective …, 2023 - Elsevier
Background Patients with missed miscarriages are usually accompanied by varying degrees
of depression, which is closely related to the patient's prognosis. We investigated whether …

[HTML][HTML] Clinical utility of mifepristone: apprising the expanding horizons

ZV Karena, H Shah, H Vaghela, K Chauhan, PK Desai… - Cureus, 2022 - ncbi.nlm.nih.gov
Mifepristone is a progesterone and glucocorticoid receptor antagonist. Medical abortion with
mifepristone and prostaglandin has revolutionized the abortion process extending abortion …

Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States

D Calloway, DB Stulberg, E Janiak - Contraception, 2021 - Elsevier
Despite its safety record, mifepristone is subject to a highly restrictive set of regulatory
measures through the Risk Evaluation and Mitigation Strategy (REMS) by the US Food and …

Comparison of early pregnancy loss management between states with restrictive and supportive abortion policies

E Tal, R Paul, M Dorsey, T Madden - Women's health issues, 2023 - Elsevier
Introduction Mifepristone–misoprostol and office uterine aspiration used for abortion care
are also evidence-based, cost-effective strategies for early pregnancy loss management. We …

Management of pregnancy after radical trachelectomy

Y Kasuga, S Ikenoue, M Tanaka, D Ochiai - Gynecologic Oncology, 2021 - Elsevier
Radical trachelectomy (RT) is a surgery for early-stage cervical cancer treatment that
preserves the childbearing ability, and its use has become increasingly common worldwide …

[HTML][HTML] Comparison of outpatient with inpatient mifepristone usage for cervical ripening: A randomised controlled trial

O Baev, A Karapetian, D Babich, G Sukhikh - European Journal of …, 2023 - Elsevier
Purpose The efficacy and safety of using mifepristone for the preinduction/induction of
labour (IOL) as the only method or in combination with others has been confirmed in …